top of page

®

Joint Infection One PAP

The Joint Infection One PAP tests for a comprehensive grouping of Gram-positive and Gram-negative bacteria, yeast, and antimicrobial resistance genes commonly associated with joint infections.

Joint Infection One PAP Panel Menu

Performance: 91.7% sensitivity and 99.8% specificity 
Sample Type: 0.2 mL of synovial fluid

​

Joint Infection Panel 

GRAM-POSITIVE BACTERIA:

 

Anaerococcus prevotii/vaginalis

Clostridium perfringens

Cutibacterium avidum/granulosum 

Enterococcus faecalis

Enterococcus faecium

Finegoldia magna

Parvimonas micra

Peptoniphilus

Peptostreptococcus anaerobius

Staphylococcus aureus

Staphylococcus lugdunensis

Streptococcus spp.

Streptococcus agalactiae

Streptococcus pneumoniae

Streptococcus pyogenes

​

YEAST:

​

Candida spp.

Candida albicans

​

​

ANTIMICROBIAL RESISTANCE GENES:


Carbapenemases


 IMP


•KPC


•NDM


• Oxa-48-like

• VIM


ESBL

 CTX-M


Methicillin Resistance

• mecA/C and MREJ (MRSA)


Vancomycin Resistance

• vanA/B

GRAM-NEGATIVE BACTERIA:

​

Bacteroides fragilis

Citrobacter

Enterobacter cloacae complex

Escherichia coli

Haemophilus influenzae

Kingella kingae

Klebsiella aerogenes

Klebsiella pneumoniae group

Morganella morganii

Neisseria gonorrhoeae

Proteus spp.

Pseudomonas aeruginosa

Salmonella spp.

Serratia marcescens

​

PCG dots _edited.jpg
AdobeStock_382338962_edited_edited.png

Eliminate the Guesswork

Conventional testing for joint infections is complex, often requiring multiple patient samples, various send-out tests, and days of waiting for results. The Joint Infection One PAP is a rapid syndromic test that delivers comprehensive results in one easy-to-read report.

​

Using PCR technology, the The Joint Infection One PAP offers a rapid sample-to-answer turnaround without sacrificing performance.

Detect More Targets in Less Time

The Joint Infection One PAP identifies pathogens and antimicrobial resistance markers at the molecular level, encompassing the common causes of joint infections. It is not impacted by prior antibiotic use and targets difficult-to-grow anaerobes.

​

Compared to conventional methods, it can help facilitate increased diagnostic yield and improved polymicrobial detection.

Screenshot 2023-02-22 at 7.41.42 AM.png

Ultra Solutions

Molecular Reporting 

bottom of page
src="https://www.googletagmanager.com/gtag/js?id=G-RMJ50BG0P4">